Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 47 Breast Neoplasms 32 Colorectal Neoplasms 28 Prostatic Neoplasms 27 Lung Neoplasms 17 Hematopoietic and Lymphatic System Neoplasm 13 Hematologic Neoplasms 12 Ovarian Neoplasms 11 Uterine Cervical Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Lymphoma 7 Leukemia 7 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Depression 6 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Leukemia, Myeloid, Acute 5 Urinary Bladder Neoplasms 4 Mouth Neoplasms 4 Motor Activity 4 Melanoma 4 Malignant Solid Neoplasm 4 Hematopoietic and Lymphoid System Neoplasm 4 Gastrointestinal Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Anxiety Disorders 4 Advanced Cancer 4

Interventions

pimodivir 1 Sunitinib 1 Rosuvastatin Calcium 1 Olive Oil 1 Midazolam 1 Interviews as Topic 1 Cyclosporine 1 Control Groups 1 Blood Specimen Collection 1 Adalimumab 1 (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Healthy × Interviews as Topic × Clear all

NCT02378363 2015-03-04

RISCOLAIRE

Institut de Cancérologie de la Loire

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡